Consult an Expert
Trademark
Design Registration
Consult an Expert
Trademark
Copyright
Patent
Infringement
Design Registration
More
Consult an Expert
Consult an Expert
Trademark
Design Registration
Login
Patent search/
APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
Patent Search in India
Extensive patent search conducted by a registered patent agent
Patent search done by experts in under 48hrs
₹999
₹399
Talk to expert
Abstract
Information
Inventors
Applicants
Specification
Documents
APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
PCT NATIONAL PHASE APPLICATION
Published
Filed on 2 April 2014
Patent Information
| Application ID | 2617/DELNP/2014 |
| Date of Application | 02/04/2014 |
Documents
| Name | Date |
|---|---|
| 2617-DELNP-2014-Correspondence-180221.pdf | 17/10/2021 |
| 2617-DELNP-2014-Power of Attorney-180221.pdf | 17/10/2021 |
| 2617-DELNP-2014-US(14)-ExtendedHearingNotice-(HearingDate-12-11-2020).pdf | 17/10/2021 |
| 2617-DELNP-2014-US(14)-HearingNotice-(HearingDate-13-10-2020).pdf | 17/10/2021 |
| 2617-DELNP-2014-Correspondence to notify the Controller [14-10-2020(online)].pdf | 14/10/2020 |
| 2617-DELNP-2014-REQUEST FOR ADJOURNMENT OF HEARING UNDER RULE 129A [08-10-2020(online)].pdf | 08/10/2020 |
| 2617-DELNP-2014-FORM 3 [07-08-2020(online)].pdf | 07/08/2020 |
| 2617-DELNP-2014-FORM-26 [02-07-2020(online)].pdf | 02/07/2020 |
| 2617-DELNP-2014-Response to office action [02-07-2020(online)].pdf | 02/07/2020 |
| 2617-DELNP-2014-FORM 3 [10-02-2020(online)].pdf | 10/02/2020 |
| 2617-DELNP-2014-FORM 3 [22-08-2019(online)].pdf | 22/08/2019 |
| 2617-DELNP-2014-FORM 3 [30-03-2019(online)].pdf | 30/03/2019 |
| 2617-DELNP-2014-CLAIMS [31-10-2018(online)].pdf | 31/10/2018 |
| 2617-DELNP-2014-COMPLETE SPECIFICATION [31-10-2018(online)].pdf | 31/10/2018 |
| 2617-DELNP-2014-FER_SER_REPLY [31-10-2018(online)].pdf | 31/10/2018 |
| 2617-DELNP-2014-OTHERS [31-10-2018(online)].pdf | 31/10/2018 |
| 2617-DELNP-2014-Information under section 8(2) (MANDATORY) [25-10-2018(online)].pdf | 25/10/2018 |
| 2617-DELNP-2014-FORM 4(ii) [05-09-2018(online)].pdf | 05/09/2018 |
| 2617-DELNP-2014-FORM 3 [07-08-2018(online)].pdf | 07/08/2018 |
| 2617-DELNP-2014-FER.pdf | 20/03/2018 |
| 2617-DELNP-2014-FORM 3 [02-02-2018(online)].pdf | 02/02/2018 |
| 2617-DELNP-2014-FORM 3 [04-08-2017(online)].pdf | 04/08/2017 |
| 2617-delnp-2014-Correspondence-Others-(30-09-2014).pdf | 30/09/2014 |
| 2617-delnp-2014-Form-3-(30-09-2014).pdf | 30/09/2014 |
| 2617-delnp-2014-Correspondence-Others-(24-07-2014).pdf | 24/07/2014 |
| 20648-137-SPECIFICATION.pdf | 03/04/2014 |
| AbbVie Inc.pdf | 03/04/2014 |
| FORM-3.pdf | 03/04/2014 |
| FORM-5.pdf | 03/04/2014 |
| IB304.pdf | 03/04/2014 |
